The most consistent defect in mitochondrial electron transport system (ETS) enzymes in AD is the deficiency in cytochrome c oxidase (complex IV) activity in post-mortem brain tissues of AD patients [17]–[19] and APP transgenic mice [20], as well as in other tissues, such as platelets from AD patients and AD cybrid cells [21], [22]. This evidence concerns the gene APP and Alzheimer disease.